C Fournier

Summary

Affiliation: CHRU de Lille
Country: France

Publications

  1. ncbi [Measurement of daily physical activity in patients with cystic fibrosis]
    C Fournier
    Centre de Ressources et Compétences pour la Mucoviscidose, Clinique des Maladies Respiratoires, Hopital Calmette, CHRU, Lille, France
    Rev Mal Respir 22:63-9. 2005
  2. ncbi [Developping real time lymph node aspiration under endobronchial ultrasound control. One year's French experience in two different pulmonary departments]
    C Fournier
    Service d Endoscopie respiratoire, pôle des maladies respiratoires, Hopital Calmette, CHRU de Lille, France
    Rev Mal Respir 25:847-52. 2008
  3. ncbi [Cardiopulmonary exercise testing in exercise-induced pulmonary hypertension]
    C Chenivesse
    Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 23:141-8. 2006
  4. ncbi Positional hyperventilation-induced hypoxaemia in pectus excavatum
    B Wallaert
    Clinique des Maladies Respiratoires, Hopital Albert Calmette, Boulevard du Pr Jules Leclercq, 59037 Lille Cedex, France
    Eur Respir J 28:243-7. 2006
  5. ncbi Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomized phase II trial
    S Clisant
    Centre Oscar Lambret, Lille, France Hopital Saint Vincent, Lille, France CHRU, Lille, France
    J Clin Oncol 27:e13519. 2009
  6. ncbi Oral metronomic cyclophosphamide (OMC) versus megestrol acetate (MA) among patients with advanced, refractory and progressive solid tumours: A randomized phase II study
    N Penel
    Centre Oscar Lambret, Lille, France CHRU Lille, Lille, France
    J Clin Oncol 26:20603. 2008
  7. doi [Diagnostic performance of EBUS-TBNA in patients with mediastinal lymphadenopathy and extrathoracic malignancy]
    G Tercé
    Pôle cardiovasculaire et pulmonaire, Clinique de Pneumologie, Hopital Calmette, CHRU de Lille, 59000 Lille, France
    Rev Mal Respir 30:758-63. 2013
  8. ncbi [Exertional dyspnoea with a normal chest]
    C Chenivesse
    Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 22:1049-51. 2005
  9. doi [Ki67 in young patients with breast cancer]
    F Vasseur
    Département de Sénologie, Centre Oscar Lambret, 3 Rue Frederic Combemale, Lille, France
    Gynecol Obstet Fertil 41:16-9. 2013
  10. pmc A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
    A Adenis
    1 Department of Medical Oncology, Centre Oscar Lambret, 3, rue F Combemale, Lille, France 2 Catholic University of Lille, Medical School, Lille, France
    Br J Cancer 109:2574-8. 2013

Collaborators

Detail Information

Publications29

  1. ncbi [Measurement of daily physical activity in patients with cystic fibrosis]
    C Fournier
    Centre de Ressources et Compétences pour la Mucoviscidose, Clinique des Maladies Respiratoires, Hopital Calmette, CHRU, Lille, France
    Rev Mal Respir 22:63-9. 2005
    ..The aim of this prospective study was to measure physical daily activity (PDA) in CF-patients and compare it with rest pulmonary functions and exercise tolerance...
  2. ncbi [Developping real time lymph node aspiration under endobronchial ultrasound control. One year's French experience in two different pulmonary departments]
    C Fournier
    Service d Endoscopie respiratoire, pôle des maladies respiratoires, Hopital Calmette, CHRU de Lille, France
    Rev Mal Respir 25:847-52. 2008
    ..This procedure is aid for diagnosis and for mediastinal staging. French pulmonary departments have been slow to introduce this technique compared to other countries...
  3. ncbi [Cardiopulmonary exercise testing in exercise-induced pulmonary hypertension]
    C Chenivesse
    Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 23:141-8. 2006
    ..To determine the accuracy of cardiopulmonary exercise-testing (CPET) in detecting exercise-induced pulmonary hypertension...
  4. ncbi Positional hyperventilation-induced hypoxaemia in pectus excavatum
    B Wallaert
    Clinique des Maladies Respiratoires, Hopital Albert Calmette, Boulevard du Pr Jules Leclercq, 59037 Lille Cedex, France
    Eur Respir J 28:243-7. 2006
    ....
  5. ncbi Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomized phase II trial
    S Clisant
    Centre Oscar Lambret, Lille, France Hopital Saint Vincent, Lille, France CHRU, Lille, France
    J Clin Oncol 27:e13519. 2009
    ..Anecdotal responses have been reported with each treatment. We hypothesized that each treatment offer disease control without significant severe toxicity...
  6. ncbi Oral metronomic cyclophosphamide (OMC) versus megestrol acetate (MA) among patients with advanced, refractory and progressive solid tumours: A randomized phase II study
    N Penel
    Centre Oscar Lambret, Lille, France CHRU Lille, Lille, France
    J Clin Oncol 26:20603. 2008
    ..Anecdotal responses have been reported with both treatments. We hypothesize that both treatments may offer stable disease (SD) without any severe toxicity among such pts...
  7. doi [Diagnostic performance of EBUS-TBNA in patients with mediastinal lymphadenopathy and extrathoracic malignancy]
    G Tercé
    Pôle cardiovasculaire et pulmonaire, Clinique de Pneumologie, Hopital Calmette, CHRU de Lille, 59000 Lille, France
    Rev Mal Respir 30:758-63. 2013
    ..There is limited data about the diagnostic performance of EBUS-TBNA in patients with mediastinal lymphadenopathy and extrathoracic malignancy...
  8. ncbi [Exertional dyspnoea with a normal chest]
    C Chenivesse
    Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 22:1049-51. 2005
  9. doi [Ki67 in young patients with breast cancer]
    F Vasseur
    Département de Sénologie, Centre Oscar Lambret, 3 Rue Frederic Combemale, Lille, France
    Gynecol Obstet Fertil 41:16-9. 2013
    ..001). In TNBC pts, KI67 was higher in younger pts (70% [10-95] versus 38% [2-80] P=0.06). Among young pts, TNBC had a higher KI67 than non TNBC (70% [10-95 versus 20% [3-60] P<0.001)...
  10. pmc A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
    A Adenis
    1 Department of Medical Oncology, Centre Oscar Lambret, 3, rue F Combemale, Lille, France 2 Catholic University of Lille, Medical School, Lille, France
    Br J Cancer 109:2574-8. 2013
    ..Preclinical findings suggest that imatinib mesylate (IM) and metronomic cyclophosphamide (MC) combination provides synergistic antiangiogenic activity on both pericytes and endothelial cells...
  11. ncbi Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis
    S Pouwels-Fry
    Clinique des Maladies Respiratoires, Centre de compétence maladies orphelines pulmonaires, University Hospital, CHRU, Lille, France
    Sarcoidosis Vasc Diffuse Lung Dis 25:133-9. 2008
    ..Idiopathic pulmonary fibrosis (IPF) is a severe disease with no known effective therapy. Patients with IPF may develop severe increase of pulmonary arterial pressure (PAP) on exercise, the mechanisms of which is not clearly identified...
  12. pmc Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
    N Penel
    Centre Oscar Lambret, Lille, France
    Br J Cancer 102:1207-12. 2010
    ..To evaluate the antitumour activity and safety of metronomic cyclophosphamide vs megestrol acetate in progressive and advanced cancer patients having exhausted all effective therapies under standard care...
  13. doi [Treatment of malignant central airways obstruction by rigid bronchoscopy]
    B Huret
    Service d Endoscopie respiratoire, pôle des maladies respiratoires, Hopital Calmette, CHRU de Lille, 59000 Lille, France Electronic address
    Rev Mal Respir 32:477-84. 2015
    ..Endobronchial resection is now the standard treatment for tracheobronchial narrowing due to malignancy. The clinical and functional respiratory improvement has been evaluated previously but only in heterogeneous population...
  14. doi [Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration]
    S Boulanger
    Service d Endoscopie respiratoire, Clinique de Pneumologie, Hopital Calmette, Pôle cardiovasculaire et pulmonaire, CHRU de Lille, 59000 Lille, France
    Rev Mal Respir 30:351-6. 2013
    ..The aim of this study was to confirm the feasibility of molecular mutation analysis in cytologic specimens obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)...
  15. doi [Pulmonary embolism diagnosed during an endobronchial ultrasound procedure]
    O Le Rouzic
    Service d Endoscopie respiratoire, pôle des maladies respiratoires, Hopital Calmette, boulevard du Pr Leclerc, 59037 Lille Cedex, France
    Rev Mal Respir 27:775-7. 2010
    ..Pulmonary embolism occurs frequently in lung cancer. The clinical features are non-specific and the diagnosis is often missed...
  16. ncbi [Rheumatoid arthritis and cystic fibrosis]
    V Doyen
    Centre de Ressources et Compétences pour la Mucoviscidose, Clinique des Maladies Respiratoires, Hopital Calmette, CHRU, Lille, France
    Rev Mal Respir 22:667-71. 2005
    ..Inflammatory arthropathies are rare complications of cystic fibrosis (CF). We describe three cases of rheumatoid arthritis (RA) occurring in patients with this disease...
  17. ncbi Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases
    J Sarini
    Head and Neck Department, Centre Oscar Lambret, Northern France Comprehensive Cancer Center, Lille, rue Combemale, 59000 Lille, France
    Arch Otolaryngol Head Neck Surg 127:1089-92. 2001
    ..When properly monitored, conventional therapies seem feasible in older patients...
  18. ncbi A Canceropole Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma
    F Mouriaux
    CHU Caen, Caen, France Centre François Baclesse, Caen, France Centre Jean Perrin, Clermont Ferrand, France Centre Oscar Lambret, Lille, France CHRU Lille, Lille, France Centre Leon Berard, Lyon, France Centre François Leclerc, Dijon, France
    J Clin Oncol 26:9061. 2008
    ..Numerous preclinical data (for example, 75% of MUM express c-kit) suggest that Imatinib Mesylate (IM) may be a potential treatment for UMM...
  19. ncbi KI 67 in patients (pts) with breast cancer (BC) younger than age 35: A comparison with older patients treated in a single institution
    F Vasseur
    Centre Oscar Lambret, Lille, France Centre Oscar Lambret, Universite Lille Nord de France, Lille, France
    J Clin Oncol 29:e21003. 2011
    ..The aim of the study was to compare KI67 as well as histoprognostic grading (SBR), mitotic index (MI), estradiol, progesterone receptors (ER, PR) and HER2 according to age...
  20. doi Prognostic factors for adult sarcomas of head and neck
    N Penel
    Département de Cancérologie Générale, Centre Oscar Lambret, Lille, France
    Int J Oral Maxillofac Surg 37:428-32. 2008
    ..005). After taking into account grade and metastasis at presentation, quality of surgery has prognostic value. The primary aim of a multidisciplinary approach to these tumours must favour complete resection...
  21. ncbi [Malignant ovarian germ cell tumours: a trial of 36 cases]
    A Gueye
    clinique de gynécologie, Hopital Jeanne de Flandre, CHRU de Lille, Lille Cedex, France
    Gynecol Obstet Fertil 35:406-19. 2007
    ..With personal results and a review of the literature, we report the eventual interest of surgical staging in malignant ovarian germ cell tumours...
  22. ncbi [Interventional bronchoscopy in the management of lung cancer]
    P P Ramon
    Service d Endoscopie respiratoire, Hôpital Calmette CHRU, Lille, France
    Rev Mal Respir 22:8S106-11. 2005
    ..These have particular potential for the treatment of early disease. Questions remain as to the precise indications for the different techniques and of how to identify which approach is most appropriate for individual patients...
  23. ncbi [Exercise performance of patients with alveolar proteinosis]
    N Bautin
    Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 22:943-50. 2005
    ..Cardiopulmonary exercise testing (CPET) is used to evaluate the severity of interstitial lung diseases, particularly when lung function is normal. The aim of this study was to analyse exercise capacity of patients with alveolar proteinosis...
  24. ncbi Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients
    M Vanhuyse
    Centre Oscar Lambret, Lille, France
    Ann Oncol 16:1283-8. 2005
    ....
  25. ncbi Patients (pts) accessible to interview in palliative care unit: Analysis of inherent biases
    E Fournier
    Centre Oscar Lambret, Lille, France University Lille Nord de France Université de Lille 3, Villeneuve d Ascq, France
    J Clin Oncol 29:e19734. 2011
    ..The assessment of the psychological well-being is mainly based on interview and questionnaires. The aim of this study is to compare the clinical characteristics of cancer pts accessible to interview and those non accessible to interview...
  26. ncbi A randomized cross-over trial comparing single-agents capecitabine (C) and UFT plus leucovorin (LV) in patients (Pts) with advanced colorectal cancer (CRC): Preliminary data of a patient preference study
    C Peugniez
    Centre Oscar Lambret, Lille, France Centre Paul Papin, Angers, France Noroncomed Network, Lille, France Centre Hospitalier de Cholet, Cholet, France
    J Clin Oncol 29:558. 2011
    ..To help the physicians to choose between C and U, we initiated this randomized cross-over trial aimed to assess patient's preference...
  27. ncbi [A favourable outcome in yellow nail syndrome: role of respiratory physiotherapy]
    C Fournier
    Service de Pneumolgie et Immuno allergologie, Clinique des Maladies Respiratoires, Hopital Calmette, CHRU Lille, France
    Rev Mal Respir 20:969-72. 2003
    ..The yellow nail syndrome is a rare condition that is easily diagnosed but the nail manifestations are poorly understood...
  28. ncbi [Desensitisation to infliximab in patients with Crohn's disease]
    J Lelong
    Service de pneumo allergologie, Clinique des Maladies Respiratoires, Hopital Albert Calmette, CHRU, Lille, France
    Rev Mal Respir 22:239-46. 2005
    ..Infliximab infusions have been associated both with immediate and delayed reactions...
  29. ncbi [Allergic asthma due to sausage mould]
    C Talleu
    Service de Pneumologie et Immuno Allergologie, pôle des maladies respiratoires, Hopital Calmette, CHRU de Lille, France
    Rev Mal Respir 26:557-9. 2009
    ..Chronic cough is a common reason for consultation in respiratory medicine. The three most frequent causes of chronic cough are asthma, postnasal drip syndrome or rhinosinusitis, and gastro-oesophageal reflux disease...